The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Jul. 20, 2012
Applicants:

Dan T. Stinchcomb, Fort Collins, CO (US);

Jorge E. Osorio, Mount Horeb, WI (US);

Timothy D. Powell, Fort Collins, CO (US);

Jeremy C. Jones, Memphis, TN (US);

Joseph N. Brewoo, Madison, WI (US);

Inventors:

Dan T. Stinchcomb, Fort Collins, CO (US);

Jorge E. Osorio, Mount Horeb, WI (US);

Timothy D. Powell, Fort Collins, CO (US);

Jeremy C. Jones, Memphis, TN (US);

Joseph N. Brewoo, Madison, WI (US);

Assignee:

Takeda Vaccines, Inc., Deerfield, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 39/38 (2006.01); A61K 39/295 (2006.01); A61K 39/145 (2006.01); A61K 39/245 (2006.01); C12Q 1/70 (2006.01); C12N 15/863 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/863 (2013.01); A61K 39/12 (2013.01); A61K 2039/5256 (2013.01); C12N 2760/16034 (2013.01); A61K 39/00 (2013.01); A61K 39/145 (2013.01); C12N 2760/16134 (2013.01); C07K 14/005 (2013.01); C07K 2319/02 (2013.01); C12N 2710/24143 (2013.01); C12N 2760/16122 (2013.01);
Abstract

Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions having two or more influenza gene segments. In other embodiments, vaccine compositions are reported of use in a subject.


Find Patent Forward Citations

Loading…